GSA Capital Partners’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-19,966
| Closed | -$129K | – | 1719 |
|
2022
Q4 | $129K | Buy |
19,966
+4,556
| +30% | +$29.4K | 0.02% | 1276 |
|
2022
Q3 | $137K | Buy |
+15,410
| New | +$137K | 0.02% | 1313 |
|
2021
Q4 | – | Sell |
-40,153
| Closed | -$370K | – | 1624 |
|
2021
Q3 | $370K | Buy |
+40,153
| New | +$370K | 0.04% | 884 |
|
2021
Q1 | – | Sell |
-23,606
| Closed | -$256K | – | 1301 |
|
2020
Q4 | $256K | Sell |
23,606
-24,333
| -51% | -$264K | 0.04% | 828 |
|
2020
Q3 | $466K | Buy |
47,939
+33,335
| +228% | +$324K | 0.08% | 439 |
|
2020
Q2 | $116K | Buy |
+14,604
| New | +$116K | 0.06% | 456 |
|
2019
Q3 | – | Sell |
-13,129
| Closed | -$123K | – | 1559 |
|
2019
Q2 | $123K | Buy |
+13,129
| New | +$123K | 0.01% | 1321 |
|